Dividend21 May 2026, 04:51 pm
Sudeep Pharma Recommends ₹1.50 Dividend for FY26
AI Summary
Sudeep Pharma Ltd's Board of Directors, in a meeting held on May 21, 2026, recommended a final dividend of ₹1.50 (150%) per equity share of ₹1 each for the financial year ended March 31, 2026, subject to shareholder approval. The board also approved the appointment of M/s. Chetan Gandhi & Associates as the Cost Auditor for FY 2026-27 and M/s H M Mehta & Associates as the Secretarial Auditor for five years commencing from FY 2026-27 until 2030-31.
Key Highlights
- Sudeep Pharma recommends a final dividend of ₹1.50 per share for FY26.
- Dividend is subject to shareholder approval at the upcoming AGM.
- Chetan Gandhi & Associates appointed as Cost Auditor for FY27.
- H M Mehta & Associates appointed as Secretarial Auditor for 5 years (FY27-FY31).
Price Impact
More from SUDEEPPHRM